Oculis |
Further advance our lead candidates: OCS-01 as a new therapeutic option for DME and post-cataract inflammation and OCS-02 for front-of-the-eye inflammation ...
Address
Tel
Website
Date
|
Product Description
|
Supplier
|
Money
|
Quantity
|
Weight
|
---|
ocul's website is ocul.is